Government Regulation of Drug Pricing and the Evolving Pharmaceutical Supply Chain
Theresa Carnegie discusses both federal and state activity regarding the regulation of drug pricing and how new entrants to the market, among other factors, are changing traditional pharmaceutical supply chain industry paradigms.
Author
Theresa C. Carnegie
Member
Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.